NCT06664203 Efficacy of Variable Volume Truncal Blocks in Upper Limb Orthopedic Surgery
| NCT ID | NCT06664203 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gaziosmanpasa Research and Education Hospital |
| Condition | Pain Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-11-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
aim of this study is to compare the effect of selective truncal blocks, performed at different doses and volumes, on the onset times of motor and sensory blocks required for anesthesia in patients scheduled for hand, wrist, forearm, and elbow surgeries. Completing the operation under regional anesthesia will be considered a successful block.
Eligibility Criteria
Inclusion Criteria: * ASA 1-2 * Body Mass Index (BMI) of 18-35 kg/m² * Age: 18-65 years -Patients undergoing all upper extremity orthopedic surgeries, except shoulder surgeries (distal humerus, elbow, forearm, hand, and wrist), will be included. - Exclusion Criteria: * Patient refusal * Pregnancy or breastfeeding * Severe pulmonary disease * Contralateral diaphragm paralysis * Nerve injury secondary to trauma * Neuromuscular disease * Peripheral neuropathy * Bleeding diathesis * Allergy to local anesthetics and dexamethasone * Uncontrolled diabetes mellitus * Morbid obesity with BMI \>35 * Severe cardiovascular, renal, or hepatic disease * Infection at the site of the nerve block
Contact & Investigator
Serpil Sehirlioglu, MD
PRINCIPAL INVESTIGATOR
Gaziosmanpasa Research and Training Hospital
Frequently Asked Questions
Who can join the NCT06664203 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Pain Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06664203 currently recruiting?
Yes, NCT06664203 is actively recruiting participants. Contact the research team at drserpilsahin@gmail.com for enrollment information.
Where is the NCT06664203 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06664203 clinical trial?
NCT06664203 is sponsored by Gaziosmanpasa Research and Education Hospital. The principal investigator is Serpil Sehirlioglu, MD at Gaziosmanpasa Research and Training Hospital. The trial plans to enroll 60 participants.